Does TOFACITINIB Cause Atelectasis? 106 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Atelectasis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
106
Reports of Atelectasis with TOFACITINIB
0.1%
of all TOFACITINIB reports
19
Deaths
33
Hospitalizations
How Dangerous Is Atelectasis From TOFACITINIB?
Of the 106 reports, 19 (17.9%) resulted in death, 33 (31.1%) required hospitalization, and 25 (23.6%) were considered life-threatening.
Is Atelectasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Atelectasis?
PREDNISONE (446)
ALBUTEROL (317)
METHOTREXATE (307)
CYCLOPHOSPHAMIDE (268)
DOXORUBICIN (215)
ADALIMUMAB (214)
ONDANSETRON (202)
RITUXIMAB (197)
DEXAMETHASONE (196)
PACLITAXEL (189)
Which TOFACITINIB Alternatives Have Lower Atelectasis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN